Viatris partners with Unmind to improve employee mental health

PITTSBURGH – Global healthcare company Viatris Inc. (NASDAQ: NASDAQ: ) has expanded its employee well-being initiatives with the launch of Unmind, a workplace mental health resource. The initiative is part of the company's wider Elevate program, which aims to improve the health and well-being of its employees.

Unmind, known for its workplace mental health solutions, is now available to Viatris employees and their families. Designed by psychologists, the program provides confidential resources to support individuals in proactively managing their mental health. It provides personalized tools to help improve all aspects of health, including stress management, sleep improvement, and overall well-being.

The launch of Unmind aligns with Viatris' commitment to employee wellness, purpose and growth. Andrew Enrietti, the company's chief people officer, emphasized the importance of mental health and the role of the Elevate program in creating a supportive work environment. The program's principles focus on physical and mental health, meaningful community involvement, and personal and professional development.

According to the World Health Organization, mental health conditions such as depression and anxiety increased by more than 25% in the first year of the Covid-19 pandemic. This surge highlights the need for organizations to prioritize employee well-being. Viatris responded by ensuring all colleagues around the world have access to mental health tools and support by 2024.

Sheila Muhl, head of total rewards and talent at Viatris, highlighted the company's unique position to support employee health and well-being through its partnership with Unmind. The scheme's supporter network, made up of around 300 volunteer colleagues, facilitates the delivery of Unmind and promotes mental health discussions within the company.

3rd party advertising. Not an offer or recommendation by disclosures here or
Remove ads

Unmind co-founder and CEO Dr. Nick Taylor expressed enthusiasm for the collaboration, which reflects a shared vision to prioritize mental health and remove stigma around the subject in the workplace.

Headquartered in the United States with operations around the world, Viatris provides medicines to approximately 1 billion patients each year. The company's 2022 Sustainability Report provides further insight into its culture and commitment to wellness at every stage of life.

This expansion of Viatris health plans is based on a press release.

Investment Professional Insights

Viatris Inc. (NASDAQ: VTRS ) not only actively promotes mental health through its partnership with Unmind, but also demonstrates a strong commitment to creating shareholder value. InvestingPro Tip shows that management has been actively repurchasing stock, which can generally indicate confidence in a company's future prospects. Additionally, the company has a strong shareholder yield, which combines dividend payments and share buybacks to show the total dividends paid out to shareholders. This may be particularly attractive to investors looking for a company with a shareholder-friendly capital allocation policy.

On the financial side, real-time data from InvestingPro shows that Viatris had a market capitalization of $13.74 billion and an adjusted price-to-earnings (P/E) ratio of 9.78 over the trailing 12 months to Q4 2023, indicating that Viatris was trading relatively high relative to earnings. , the stock may be undervalued. The company's gross profit margin is as high as 43.64%, its production cost management is effective, and its pricing power is strong. Additionally, Viatris has been profitable over the last 12 months, with basic and diluted earnings per share of $0.05, and has strengthened the company's financial stability.

3rd party advertising. Not an offer or recommendation by disclosures here or
Remove ads

For investors interested in learning more, there are additional InvestingPro Tips that can help you gain a deeper understanding of Viatris' financial health and market performance. These include expectations for net profit growth this year and the company's status as a well-known player in the pharmaceutical industry.To get these valuable tips and more, visit and use the coupon code PRONEWS24 Annual or biennial Pro and Pro+ subscriptions receive an additional 10% discount. Viatris also provides 11 additional InvestingPro Tips to provide comprehensive analysis for informed investment decisions.

This article was generated with the support of artificial intelligence and reviewed by an editor. For more information, please see our terms and conditions.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *